Abstract:Asphyxia occurring in the fetus and newborn infant frequently leads to hypoxic‐ischemic encephalopathy (HIE) in survivors. The neonatal brain circulatory system is compromised by asphyxia/reventilation via a mechanism that may involve oxidative stress. CO, a gaseous messenger with antioxidant properties, is produced from heme via the heme oxygenase (HO)‐catalyzed reaction. We tested the hypothesis that CO, either produced by the brain, or delivered systemically by the donor molecule CORM‐A1, has a cerebrovascular protective role during neonatal asphyxia. We developed a novel survival model of prolonged asphyxia (50 – 60 min) in newborn pigs that combines insults of severe hypoxia (PaO 2 , 20–30 mm Hg), hypercapnia (PaCO 2 , 70–80 mm Hg), and acidosis (pH, 6.9–7.0) while avoiding extreme systemic hypotension and cerebral ischemia. During the asphyxia conditions, we observed immediate and sustained activation of brain HO as detected by an elevated CO concentration in the cortical periarachnoid fluid. Cortical astrocytes are among the main sources of brain CO production in normal and asphyxiated brains. Asphyxia followed by a 60‐min reventilation with room air caused excessive formation of reactive oxygen species (ROS) in the neonatal brain. Brain oxidative stress was potentiated by the HO inhibitor tin protoporphyrin, suggesting that activation of astrocytic HO/CO during asphyxia has antioxidant effects. Administered 30 min before asphyxia, CORM‐A1 (2 mg/kg i.p.) prevented excessive ROS formation in the brain during reventilation. We tested the effects of prolonged neonatal asphyxia on cerebral vascular dilator functions after 24 and 48 h of recovery using the cranial window technique. Endothelium‐dependent vasodilatory responses to hypercapnia and bradykinin were not negatively affected by prolonged asphyxia. In contrast, astrocyte‐dependent cerebral vasodilatory responses to adenosine diphosphate (ADP) and glutamate were compromised, indicating that astrocytes are selectively injured by prolonged asphyxia. Endothelium‐ and astrocyte‐independent cerebral vascular smooth muscle functions tested by vasodilations to isoproterenol and sodium nitroprusside remained intact in post‐asphyxic newborn pigs. In CORM‐A1‐pretreated animals, prolonged asphyxia did not produce any cerebral vascular incapacities, suggesting that CO therapy protects astrocytes from asphyxia/reventilation injury. Overall, prolonged neonatal asphyxia without systemic hypotension or cerebral ischemia injures cortical astrocytes via an oxidative stress‐mediated mechanism that can be partially counteracted by activation of the endogenous HO/CO‐based antioxidant system in the brain or by CO/CORM‐A1 therapy. We propose that gaseous CO and CO donor molecules can be used as novel efficient therapeutic approaches to prevention of neonatal brain injury caused by prolonged asphyxia. Support or Funding Information R01 NS 101717; R01 HL 034059; R01 HL 042851 This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .

Carbon dioxide influence on nitric oxide production in endothelial cells and astrocytes: cellular mechanisms

Effects of Hypoxia on Levels of Nitric Oxide, Endothelin- 1 and Inducible Nitric Oxide Synthase Mrna Expression in Cultured Human Umbilical Vein Endothelial Cells

Astrocytes produce nitric oxide via nitrite reduction in mitochondria to regulate cerebral blood flow during brain hypoxia

Nitric Oxide Regulation of Myocardial O-2 Consumption and Hep Metabolism

The influence of carbon dioxide on cerebral metabolism and oxygen consumption: combining multimodal monitoring with dynamic systems modelling

Nitric oxide and cerebrovascular regulation

The influence of basal CO2 on neurofluid dynamics measured using resting-state BOLD fMRI

The Influence of Oxygen-Glucose Deprivation on Nitric Oxide and Intracellular Ca2+ in Cultured Hippocampal Neurons

Nitric Oxide Modulates Hypoxic Pulmonary Smooth Muscle Cell Proliferation and Apoptosis by Regulating Carbon Monoxide Pathway

Carbon monoxide as an endogenous vascular modulator

Antioxidant and Cerebroprotective Roles of Carbon Monoxide (CO) Against Cerebrovascular Injury Caused by Prolonged Neonatal Asphyxia

Nitric oxide induces the expression of the monocarboxylate transporter MCT4 in cultured astrocytes by a cGMP-independent transcriptional activation

HIF-1α subunit and vasoactive HIF-1-dependent genes are involved in carbon monoxide-induced cerebral hypoxic stress response

Rapid Ca2+-dependent NO-production from central nervous system cells in culture measured by NO-nitrite/ozone chemoluminescence

The role of nitric oxide in neurovascular coupling

Contributions of astrocytes and CO to pial arteriolar dilation to glutamate in newborn pigs

Effect on Cerebral Focal Ischemic Tissue by Endogenous Carbon Monoxide and Nitric Oxide

Control of the neurovascular coupling by nitric oxide-dependent regulation of astrocytic Ca(2+) signaling

Acute Chemogenetic Inhibition of Caudal NTS Astrocytes Reduced Systemic Blood Pressure in Rats Exposed to Chronic Intermittent Hypoxia‐mimicking Sleep Apnea Syndrome

Endogenous nitric oxide regulates heme oxygenase/carbon monoxide system in intrapulmonary arteries of hypoxic rats

Mechanisms underlying β2-adrenoceptor-mediated nitric oxide generation by human umbilical vein endothelial cells